Verrica Pharmaceuticals Statistics

Total Valuation

VRCA has a market cap or net worth of $45.02 million. The enterprise value is $44.63 million.

Market Cap	45.02M
Enterprise Value	44.63M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

VRCA has 91.78 million shares outstanding. The number of shares has increased by 14.26% in one year.

Current Share Class	91.78M
Shares Outstanding	91.78M
Shares Change (YoY)	+14.26%
Shares Change (QoQ)	+43.84%
Owned by Insiders (%)	44.70%
Owned by Institutions (%)	14.86%
Float	34.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.36
Forward PS	2.17
PB Ratio	-4.57
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.76

Current Ratio	1.76
Quick Ratio	1.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.91

Financial Efficiency

Return on equity (ROE) is -1,546.58% and return on invested capital (ROIC) is -80.21%.

Return on Equity (ROE)	-1,546.58%
Return on Assets (ROA)	-59.89%
Return on Invested Capital (ROIC)	-80.21%
Return on Capital Employed (ROCE)	-258.88%
Revenue Per Employee	$106,563
Profits Per Employee	-$1.08M
Employee Count	71
Asset Turnover	0.11
Inventory Turnover	8.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -93.04% in the last 52 weeks. The beta is 1.68, so VRCA's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	-93.04%
50-Day Moving Average	0.59
200-Day Moving Average	1.98
Relative Strength Index (RSI)	46.67
Average Volume (20 Days)	614,000

Short Selling Information

The latest short interest is 2.85 million, so 3.10% of the outstanding shares have been sold short.

Short Interest	2.85M
Short Previous Month	2.22M
Short % of Shares Out	3.10%
Short % of Float	8.32%
Short Ratio (days to cover)	5.30

Income Statement

In the last 12 months, VRCA had revenue of $7.57 million and -$76.58 million in losses. Loss per share was -$1.48.

Revenue	7.57M
Gross Profit	-7.01M
Operating Income	-65.04M
Pretax Income	-80.74M
Net Income	-76.58M
EBITDA	-64.08M
EBIT	-65.04M
Loss Per Share	-$1.48

Full Income Statement

Balance Sheet

The company has $46.33 million in cash and $45.94 million in debt, giving a net cash position of $390,000 or $0.00 per share.

Cash & Cash Equivalents	46.33M
Total Debt	45.94M
Net Cash	390,000
Net Cash Per Share	$0.00
Equity (Book Value)	-9.86M
Book Value Per Share	-0.11
Working Capital	22.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$60.93 million and capital expenditures -$27,000, giving a free cash flow of -$60.95 million.

Operating Cash Flow	-60.93M
Capital Expenditures	-27,000
Free Cash Flow	-60.95M
FCF Per Share	-$0.66

Full Cash Flow Statement

Margins

Gross Margin	-92.70%
Operating Margin	-859.58%
Pretax Margin	-1,012.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VRCA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.26%
Shareholder Yield	n/a
Earnings Yield	-170.11%
FCF Yield	-135.40%

Analyst Forecast

The average price target for VRCA is $6.00, which is 1,130.77% higher than the current price. The consensus rating is "Hold".

Price Target	$6.00
Price Target Difference	1,130.77%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	77.71%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VRCA has an Altman Z-Score of -9.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.37
Piotroski F-Score	4